Sensus Healthcare Launches Treat Skin Cancer to Empower Patients Navigating Non-Melanoma Skin Cancer

Treat Skin Cancer from Sensus Healthcare

Patient-Centric Resource Delivers Educational Resources to Help Patients Make Informed Decisions

Sensus Healthcare Inc. (NASDAQ:SRTS)

BOCA RATON, FL, UNITED STATES, September 15, 2026 /EINPresswire.com/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the launch of Treat Skin Cancer (treatskincancer.com), a comprehensive public awareness and patient education campaign designed to guide individuals through every phase of a non-melanoma skin cancer diagnosis.

One in five Americans will be diagnosed with skin cancer by the time they are 70. Each year, more than five million patients will be diagnosed with non-melanoma skin cancer. Non-melanoma skin cancer occurs in the top layer of the skin and presents most commonly as basal cell carcinoma and squamous cell carcinoma. When caught early, non-melanoma skin cancer can have cure rates higher than 95%.

"A skin cancer diagnosis feels overwhelming to patients, who suddenly have a new world to navigate,” said Joe Sardano, CEO, Sensus Healthcare. “We’ve built Treat Skin Cancer as an educational resource to empower patients to find essential information so they have support throughout their entire patient journey, from diagnosis to treatment and life beyond.”

The Treat Skin Cancer educational platform includes evidence-based facts and insights to support patients in their journeys of educating themselves about skin cancer. Comprehensive treatment comparisons, and discussion and decision guides, offer another layer of support to help patients understand treatment pathways and critical conversations to have with their care teams.

“With skin cancer rates continuing to rise across the country, an education-first approach is essential,” added Sardano. “At Sensus Healthcare, our goal is to support patients through every stage of their journey, ensuring they have the knowledge and resources to choose the care that best fits their unique health needs and priorities.”

To learn more about the campaign and explore the educational resources, visit treatskincancer.com.

About Sensus Healthcare
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.

Tony Berlin
Berlin Media Relations
email us here